Predictors of first recurrence of clostridium difficile infections in children

Pediatric Infectious Disease Journal

Volumn 33, Issue 4, 2014, Pages 414-416

  Tschudin Sutter, Sarah ^a,b   Tamma, Pranita D ^a   Milstone, Aaron M ^a,b   Perl, Trish M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Diarrhea; Infections; Pediatrics

Indexed keywords

AMINOGLYCOSIDE; ANTACID AGENT; ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; MACROLIDE; PENICILLIN DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHILDHOOD DISEASE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT INFECTION; RETROSPECTIVE STUDY; SCHOOL CHILD; ADOLESCENT; ADULT; CLOSTRIDIUM INFECTIONS; DIARRHEA; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; RECURRENT DISEASE; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; FEMALE; HUMANS; INFANT; MALE; RECURRENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84897023313     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000108     Document Type: Article

References (11)

1. Schutze GE, Willoughby RE; Committee on Infectious Diseases; American Academy of Pediatrics. Clostridium difficile infection in infants and children. Pediatrics. 2013;131:196-200.
2. Aslam S, Hamill RJ, Musher DM. Treatment of Clostridium difficileassociated disease: Old therapies and new strategies. Lancet Infect Dis. 2005;5:549-557.
3. Petrella LA, Sambol SP, Cheknis A, et al. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin Infect Dis. 2012;55:351-357.
4. Garey KW, Sethi S, Yadav Y, et al. Meta-Analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect. 2008;70:298-304.
5. Khanna S, Baddour LM, Huskins WC, et al. The epidemiology of Clostridium difficile infection in children: A population-based study. Clin Infect Dis. 2013.
6. Kim J, Shaklee JF, Smathers S, et al. Risk factors and outcomes associated with severe clostridium difficile infection in children. Pediatr Infect Dis J. 2012;31:134-138.
7. Cohen SH, Gerding DN, Johnson S, et al.; Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431-455.
8. Tamma PD, Sandora TJ. Clostridium difficile infection in children: Current state and unanswered questions. J Pediatric Infect Dis Soc. 2012;1:230-243.
9. Centers for Disease Control and Prevention (CDC). Severe Clostridium difficile-Associated disease in populations previously at low risk-four states, 2005. MMWR Morb Mortal Wkly Rep. 2005;54:1201-1205.
10. Marsh JW, Arora R, Schlackman JL, et al. Association of relapse of Clostridium difficile disease with BI/NAP1/027. J Clin Microbiol. 2012;50:4078-4082.
11. Mullane KM, Miller MA, Weiss K, et al. Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections. Clin Infect Dis. 2011;53:440-447.